Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial.

Bell KJ, Fio CZ, Twigg S, Duke SA, Fulcher G, Alexander K, McGill M, Wong J, Brand-Miller J, Steil GM.

Diabetes Care. 2020 Jan;43(1):59-66. doi: 10.2337/dc19-0687. Epub 2019 Aug 27.

PMID:
31455688
2.

Continuous Glucose Monitoring Linked to an Artificial Intelligence Risk Index: Early Footprints of Intraventricular Hemorrhage in Preterm Neonates.

Galderisi A, Zammataro L, Losiouk E, Lanzola G, Kraemer K, Facchinetti A, Galeazzo B, Favero V, Baraldi E, Cobelli C, Trevisanuto D, Steil GM.

Diabetes Technol Ther. 2019 Mar;21(3):146-153. doi: 10.1089/dia.2018.0383.

PMID:
30835533
3.

Short-Term Adverse Outcomes Associated With Hypoglycemia in Critically Ill Children.

Faustino EVS, Hirshberg EL, Asaro LA, Biagas KV, Pinto N, Srinivasan V, Bagdure DN, Steil GM, Coughlin-Wells K, Wypij D, Nadkarni VM, Agus MSD, Mourani PM, Chima R, Thomas NJ, Li S, Pinto A, Newth C, Hassinger A, Bysani K, Rehder KJ, Kandil S, Wintergerst K, Schwarz A, Marsillio L, Cvijanovich N, Pham N, Quasney M, Flori H, Federman M, Nett S, Viteri S, Schneider J, Medar S, Sapru A, McQuillen P, Babbitt C, Lin JC, Jouvet P, Yanay O, Allen C; Heart And Lung Failure-Pediatric INsulin Titration (HALF-PINT) Study Investigators.

Crit Care Med. 2019 May;47(5):706-714. doi: 10.1097/CCM.0000000000003699.

PMID:
30789401
4.

Adjusting Insulin Delivery to Activity (AIDA) clinical trial: Effects of activity-based insulin profiles on glucose control in children with type 1 diabetes.

Ortiz-Rubio P, Oladunjoye A, Agus MSD, Steil GM.

Pediatr Diabetes. 2018 Dec;19(8):1451-1458. doi: 10.1111/pedi.12752. Epub 2018 Sep 9.

PMID:
30120825
5.

Procedural Pain during Insertion of a Continuous Glucose Monitoring Device in Preterm Infants.

Galderisi A, Lago P, Steil GM, Ghirardo M, Cobelli C, Baraldi E, Trevisanuto D.

J Pediatr. 2018 Sep;200:261-264.e1. doi: 10.1016/j.jpeds.2018.03.040. Epub 2018 May 31.

PMID:
29861315
6.

Best Use of Models to Advance the Artificial Pancreas.

Steil GM.

Diabetes Technol Ther. 2018 Mar;20(3):171-173. doi: 10.1089/dia.2017.0420. Epub 2018 Feb 15. No abstract available.

PMID:
29446980
7.

Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial.

Galderisi A, Facchinetti A, Steil GM, Ortiz-Rubio P, Cavallin F, Tamborlane WV, Baraldi E, Cobelli C, Trevisanuto D.

Pediatrics. 2017 Oct;140(4). pii: e20171162. doi: 10.1542/peds.2017-1162. Epub 2017 Sep 15.

8.

Tight Glycemic Control in Critically Ill Children.

Agus MS, Wypij D, Hirshberg EL, Srinivasan V, Faustino EV, Luckett PM, Alexander JL, Asaro LA, Curley MA, Steil GM, Nadkarni VM; HALF-PINT Study Investigators and the PALISI Network.

N Engl J Med. 2017 Feb 23;376(8):729-741. doi: 10.1056/NEJMoa1612348. Epub 2017 Jan 24.

9.
10.

Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes: Application of a Model-Based Approach to Derive Insulin Doses for Open-Loop Diabetes Management.

Bell KJ, Toschi E, Steil GM, Wolpert HA.

Diabetes Care. 2016 Sep;39(9):1631-4. doi: 10.2337/dc15-2855. Epub 2016 Jul 7.

PMID:
27388474
11.

Bolus Estimation--Rethinking the Effect of Meal Fat Content.

Laxminarayan S, Reifman J, Edwards SS, Wolpert H, Steil GM.

Diabetes Technol Ther. 2015 Dec;17(12):860-6. doi: 10.1089/dia.2015.0118. Epub 2015 Aug 13.

12.

The artificial pancreas: evaluating risk of hypoglycaemia following errors that can be expected with prolonged at-home use.

Wolpert H, Kavanagh M, Atakov-Castillo A, Steil GM.

Diabet Med. 2016 Feb;33(2):235-42. doi: 10.1111/dme.12823. Epub 2015 Jul 4.

13.

Impact of fat, protein, and glycemic index on postprandial glucose control in type 1 diabetes: implications for intensive diabetes management in the continuous glucose monitoring era.

Bell KJ, Smart CE, Steil GM, Brand-Miller JC, King B, Wolpert HA.

Diabetes Care. 2015 Jun;38(6):1008-15. doi: 10.2337/dc15-0100. Review.

PMID:
25998293
14.

Tight glycemic control in the ICU - is the earth flat?

Steil GM, Agus MS.

Crit Care. 2014 Jun 27;18(3):159. doi: 10.1186/cc13950.

15.

Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trial.

Agus MS, Asaro LA, Steil GM, Alexander JL, Silverman M, Wypij D, Gaies MG; SPECS Investigators.

Circulation. 2014 Jun 3;129(22):2297-304. doi: 10.1161/CIRCULATIONAHA.113.008124. Epub 2014 Mar 26.

16.
17.

The artificial pancreas: is it important to understand how the β cell controls blood glucose?

Steil GM, Grodsky GM.

J Diabetes Sci Technol. 2013 Sep 1;7(5):1359-69. Review.

18.

Cardiac output assessed by non-invasive monitoring is associated with ECG changes in children with critical asthma.

Wong J, Dorney K, Hannon M, Steil GM.

J Clin Monit Comput. 2014 Feb;28(1):75-82. doi: 10.1007/s10877-013-9498-6. Epub 2013 Jul 20.

PMID:
23873137
19.

Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*.

Decourcey DD, Steil GM, Wypij D, Agus MS.

Pediatr Crit Care Med. 2013 Sep;14(7):694-700. doi: 10.1097/PCC.0b013e3182975cab.

PMID:
23863818
21.
22.

Cardiac parameters in children recovered from acute illness as measured by electrical cardiometry and comparisons to the literature.

Wong J, Agus MS, Steil GM.

J Clin Monit Comput. 2013 Feb;27(1):81-91. doi: 10.1007/s10877-012-9401-x. Epub 2012 Oct 6.

PMID:
23054385
23.

Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial.

Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM.

Diabetes Care. 2013 Feb;36(2):222-7. doi: 10.2337/dc12-1079. Epub 2012 Oct 1.

24.

Tight glycemic control versus standard care after pediatric cardiac surgery.

Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL, Scoppettuolo LA, Pigula FA, Charpie JR, Ohye RG, Gaies MG; SPECS Study Investigators.

N Engl J Med. 2012 Sep 27;367(13):1208-19. Epub 2012 Sep 7.

25.

Design and rationale of safe pediatric euglycemia after cardiac surgery: a randomized controlled trial of tight glycemic control after pediatric cardiac surgery.

Gaies MG, Langer M, Alexander J, Steil GM, Ware J, Wypij D, Laussen PC, Newburger JW, Goldberg CS, Pigula FA, Shukla AC, Duggan CP, Agus MS; Safe Pediatric Euglycemia after Cardiac Surgery Study Group.

Pediatr Crit Care Med. 2013 Feb;14(2):148-56. doi: 10.1097/PCC.0b013e31825b549a.

26.

The identifiable virtual patient model: comparison of simulation and clinical closed-loop study results.

Kanderian SS, Weinzimer SA, Steil GM.

J Diabetes Sci Technol. 2012 Mar 1;6(2):371-9.

27.

Changes in cardiac output and stroke volume as measured by non-invasive CO monitoring in infants with RSV bronchiolitis.

Caplow J, McBride SC, Steil GM, Wong J.

J Clin Monit Comput. 2012 Jun;26(3):197-205. doi: 10.1007/s10877-012-9361-1. Epub 2012 Apr 24.

PMID:
22526738
28.

Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery.

Loutseiko M, Voskanyan G, Keenan DB, Steil GM.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1342-51.

29.

Cardiovascular effects of dexmedetomidine sedation in children.

Wong J, Steil GM, Curtis M, Papas A, Zurakowski D, Mason KP.

Anesth Analg. 2012 Jan;114(1):193-9. doi: 10.1213/ANE.0b013e3182326d5a. Epub 2011 Sep 29.

PMID:
21965374
30.

Non-invasive cardiac output and oxygen delivery measurement in an infant with critical anemia.

Steil GM, Eckstein OS, Caplow J, Agus MS, Walsh BK, Wong J.

J Clin Monit Comput. 2011 Apr;25(2):113-9. doi: 10.1007/s10877-011-9287-z. Epub 2011 Jun 21.

PMID:
21691835
31.

Value of continuous glucose monitoring for minimizing severe hypoglycemia during tight glycemic control.

Steil GM, Langer M, Jaeger K, Alexander J, Gaies M, Agus MS.

Pediatr Crit Care Med. 2011 Nov;12(6):643-8. doi: 10.1097/PCC.0b013e31821926a5.

32.

The effect of insulin feedback on closed loop glucose control.

Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR.

J Clin Endocrinol Metab. 2011 May;96(5):1402-8. doi: 10.1210/jc.2010-2578. Epub 2011 Mar 2.

33.

Use of a continuous glucose sensor in an extracorporeal life support circuit.

Steil GM, Alexander J, Papas A, Monica L, Modi BP, Piper H, Jaksic T, Gottlieb R, Agus MS.

J Diabetes Sci Technol. 2011 Jan 1;5(1):93-8.

34.

Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Rebrin K, Sheppard NF Jr, Steil GM.

J Diabetes Sci Technol. 2010 Sep 1;4(5):1087-98.

35.

Update on mathematical modeling research to support the development of automated insulin delivery systems.

Steil GM, Hipszer B, Reifman J.

J Diabetes Sci Technol. 2010 May 1;4(3):759-69.

36.

Delays in minimally invasive continuous glucose monitoring devices: a review of current technology.

Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1207-14. Review.

37.

Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Kanderian SS, Weinzimer S, Voskanyan G, Steil GM.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1047-57.

38.
39.

Intensive Care Unit Insulin Delivery Algorithms: Why So Many? How to Choose?

Steil GM, Deiss D, Shih J, Buckingham B, Weinzimer S, Agus MS.

J Diabetes Sci Technol. 2009 Jan;3(1):125-140.

40.
41.

Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system.

Cengiz E, Swan KL, Tamborlane WV, Steil GM, Steffen AT, Weinzimer SA.

Diabetes Technol Ther. 2009 Apr;11(4):207-10. doi: 10.1089/dia.2008.0102.

42.

Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.

Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA.

Diabetes Care. 2009 Feb;32(2):240-4. doi: 10.2337/dc08-0595. Epub 2008 Nov 18.

43.

Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.

Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.

Diabetes Care. 2008 May;31(5):934-9. doi: 10.2337/dc07-1967. Epub 2008 Feb 5.

PMID:
18252903
44.

Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes.

Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV.

Diabetes Care. 2008 Jan;31(1):44-6. Epub 2007 Oct 1. No abstract available.

PMID:
17909083
45.
46.

Feasibility of automating insulin delivery for the treatment of type 1 diabetes.

Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF.

Diabetes. 2006 Dec;55(12):3344-50.

47.

Evaluation of the effect of gain on the meal response of an automated closed-loop insulin delivery system.

Panteleon AE, Loutseiko M, Steil GM, Rebrin K.

Diabetes. 2006 Jul;55(7):1995-2000.

48.

Closed-loop insulin delivery - what lies between where we are and where we are going?

Steil GM, Rebrin K.

Expert Opin Drug Deliv. 2005 Mar;2(2):353-62. Review.

PMID:
16296759
49.

Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia.

Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF.

Diabetologia. 2005 Sep;48(9):1833-40. Epub 2005 Jul 7.

PMID:
16001232
50.

Modeling insulin action for development of a closed-loop artificial pancreas.

Steil GM, Clark B, Kanderian S, Rebrin K.

Diabetes Technol Ther. 2005 Feb;7(1):94-108.

PMID:
15738707

Supplemental Content

Loading ...
Support Center